Vimarsana
Biggest News Aggregation in the World

Page 18 - Planned Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Planned Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Planned Solutions Today - Breaking & Trending Today

Vanguard Total International Bond ETF (NASDAQ:BNDX) is Alterna Wealth Management Inc.'s 10th Largest Position - Vimarsana News

Vanguard Total International Bond ETF (NASDAQ:BNDX) is Alterna Wealth Management Inc.'s 10th Largest Position

Alterna Wealth Management Inc. increased its position in shares of Vanguard Total International Bond ETF (NASDAQ:BNDX – Free Report) by 10.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 51,077 shares of the company’s stock after buying an additional 4,937 shares during the period. Vanguard […]

Sapient Capital LLC Takes Position in SPDR Gold Shares (NYSEARCA:GLD) - Vimarsana News

Sapient Capital LLC Takes Position in SPDR Gold Shares (NYSEARCA:GLD)

Sapient Capital LLC purchased a new stake in SPDR Gold Shares (NYSEARCA:GLD – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 113,693 shares of the exchange traded fund’s stock, valued at approximately $21,735,000. Other institutional investors and hedge funds have also […]

HC Wainwright Raises Corcept Therapeutics (NASDAQ:CORT) Price Target to $40.00 - Vimarsana News

HC Wainwright Raises Corcept Therapeutics (NASDAQ:CORT) Price Target to $40.00

Corcept Therapeutics (NASDAQ:CORT – Free Report) had its price objective upped by HC Wainwright from $38.00 to $40.00 in a research note published on Thursday, Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. HC Wainwright also issued estimates for Corcept Therapeutics’ Q2 2024 earnings at $0.21 EPS, Q3 2024 earnings […]

Corcept Therapeutics (NASDAQ:CORT) Price Target Raised to $40.00 at HC Wainwright - Vimarsana News

Corcept Therapeutics (NASDAQ:CORT) Price Target Raised to $40.00 at HC Wainwright

Corcept Therapeutics (NASDAQ:CORT – Free Report) had its price objective boosted by HC Wainwright from $38.00 to $40.00 in a research note issued to investors on Thursday morning, Benzinga reports. HC Wainwright currently has a buy rating on the biotechnology company’s stock. HC Wainwright also issued estimates for Corcept Therapeutics’ Q2 2024 earnings at $0.21 […]

Source: wkrb13.com
Ifrah Financial Services Inc. Reduces Stock Position in CBRE Group, Inc. (NYSE:CBRE) - Vimarsana News

Ifrah Financial Services Inc. Reduces Stock Position in CBRE Group, Inc. (NYSE:CBRE)

Ifrah Financial Services Inc. lessened its holdings in shares of CBRE Group, Inc. (NYSE:CBRE – Free Report) by 7.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,027 shares of the financial services provider’s stock after selling 591 shares during […]